BioMotiv is the purpose-driven accelerator linked to The Harrington Project for Discovery & Development, a $340 million endeavor for progressing medicine based at University Hospitals in Cleveland. BioMotiv's emphasis is on expediting groundbreaking findings from research institutions into treatments for patients through a pioneering approach that effectively aligns funding and resources. The organization utilizes a proficient team and advisory board to choose, finance, and actively supervise and progress a collection of drug development initiatives.